Hansa Biopharma achieves Great Place to Work certification for second consecutive year
· Award granted by internationally recognized Great Place to Work institute · Based on company-wide survey completed by all Hansa employees and review of company HR policies · Metrics reflective of trust in the company, such as credibility, pride and fairness, were among those most highly rated by employees Lund, Sweden, August 25, 2021. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), the pioneer in enzyme technology for rare immunological conditions, today announced its certification as a Great Places to Work 2021. The accolade was awarded by the independent